PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in PAVmed Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +2 vs. Q1 2024
- Shares held
- 1.10M
- +142.8K (+15.0%) vs. Q1 2024
- Total value
- $931.9K
- −$1.10M (−54.1%) vs. Q1 2024
- New holders
- 6
- 5 more added
- Sold out
- 4
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PAVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $5.56M |
| Q1 2026 | 21 | $5.26M |
| Q4 2025 | 32 | $468.8K |
| Q3 2025 | 36 | $677.4K |
| Q2 2025 | 32 | $755.8K |
| Q1 2025 | 31 | $873.5K |
| Q4 2024 | 26 | $653.8K |
| Q3 2024 | 22 | $1.38M |
| Q2 2024 | 26 | $931.9K |
| Q1 2024 | 24 | $2.03M |
| Q4 2023 | 26 | $3.10M |
| Q3 2023 | 65 | $3.67M |
| Q2 2023 | 58 | $3.78M |
| Q1 2023 | 61 | $3.76M |
| Q4 2022 | 64 | $4.62M |
| Q3 2022 | 73 | $10.9M |
| Q2 2022 | 76 | $11.5M |
| Q1 2022 | 96 | $27.0M |
| Q4 2021 | 108 | $65.5M |
| Q3 2021 | 109 | $198.9M |
| Q2 2021 | 101 | $134.7M |
| Q1 2021 | 92 | $80.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding PAVmed Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 11 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Thompson Investment Management, Inc. | 4 | $3 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 7 | $6 | 0.00% | +7 | New |
| JPMorgan Chase & Co | 37 | $30 | 0.00% | +1+2.8% | Added |
| M&R Capital Management Inc | 67 | $55 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 78 | $64 | 0.00% | +78 | New |
| Bank of America Corp | 79 | $65 | 0.00% | +72+1,028.6% | Added |
| Advisor Group Holdings, Inc. | 116 | $94 | 0.00% | −12−9.4% | Reduced |
| Allworth Financial LP | 420 | $425 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 836 | $664 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,902 | $3.18K | 0.00% | −3,242−45.4% | Reduced |
| UBS Group AG | 4,795 | $3.91K | 0.00% | +4,795 | New |
| CWM, LLC | 4,672 | $4.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,068 | $4.13K | 0.00% | −61−1.2% | Reduced |
| Tower Research Capital LLC (TRC) | 9,704 | $7.91K | 0.00% | +7,247+295.0% | Added |
| XML Financial, LLC | 10,067 | $8.21K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,706 | $9.54K | 0.00% | −46−0.4% | Reduced |
| Virtu Financial LLC | 15,099 | $12.0K | 0.00% | +15,099 | New |
| State Street Corp | 20,854 | $17.0K | 0.00% | −127−0.6% | Reduced |
| Two Sigma Securities, LLC | 25,225 | $20.6K | 0.00% | +25,225 | New |
| Geode Capital Management, LLC | 73,634 | $60.0K | 0.00% | +10,274+16.2% | Added |
| BlackRock Inc. | 74,912 | $61.1K | 0.00% | 00.0% | Unchanged |
| Axiom Advisory, LLC | 38,955 | $70.7K | 0.00% | +38,955 | New |
| Vanguard Group Inc | 295,390 | $240.7K | 0.00% | −5,151−1.7% | Reduced |
| First Manhattan Co | 500,000 | $407.5K | 0.00% | +75,000+17.6% | Added |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −21,129−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −3,612−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −134−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |